Skip to main content

Table 1 Cohort demographics

From: Mediation effects of DNA methylation and hydroxymethylation on birth outcomes after prenatal per- and polyfluoroalkyl substances (PFAS) exposure in the Michigan mother–infant Pairs cohort

Maternal characteristics

Mean (SD) or percent (count)

Entire cohort n = 309*

Total methylation n = 141

5-mC + 5-hmC n = 70

Age (years)

31.53 (4.2)

31.84 (4.1)

31.80 (4.4)

Parity (count)

1.05 (1.0)

1.01 (0.9)

0.90 (0.8)

Pre-pregnancy weight (kg)

69.28 (15.2)

70.65 (16.9)

69.10 (15.7)

Pre-pregnancy BMI

25.42 (5.3)

25.80 (5.7)

25.51 (5.4)

Marital status

Married

81.6% (252)

80.1% (113)

75.7% (53)

Single

16.8% (52)

19.1% (27)

22.9% (16)

Unknown

1.6% (5)

 < 1% (1)

 < 1% (1)

Smoking status

Never

69.6% (215)

75.1% (106)

68.6% (48)

Quit before Pregnancy

12.6% (39)

13.4% (19)

12.9% (9)

Quit during Pregnancy

2.3% (7)

2.8% (4)

4.3% (3)

Smoked < 11 cigarettes/day

2.9% (9)

2.1% (3)

4.3% (3)

Unknown

12.6% (39)

6.4% (9)

10.0% (7)

Ethnicity and race

White, Non-Hispanic

81.9% (253)

81.6% (115)

72.9% (51)

Black or African American, Non-Hispanic

6.5% (20)

6.4% (9)

10.0% (7)

Hispanic

2.6% (8)

2.1% (3)

4.3% (3)

Asian, Non-Hispanic

4.5% (14)

2.8% (4)

2.9% (2)

Native American, Non-Hispanic

0.6% (2)

 < 1% (1)

1.4% (1)

Hawaiian or Pacific Islander

0.6% (2)

0% (0)

0% (0)

Multi-Ethnic/Racial

1.0% (3)

2.1% (3)

1.4% (1)

Unknown

2.3% (7)

4.3% (6)

5.7% (4)

Infant Characteristics

n = 288

  

Sex

   

 Male

48.3% (147)

48.9% (69)

52.9% (37)

 Female

51.0% (139)

51.1% (72)

47.1% (33)

Gestational Age at Birth (days)

274.49 (12.5)

276.73 (8.1)

275.86 (9.1)

Birthweight (grams)

3414.3 (533.0)

3435.0 (482.1)

3351.79 (518.9)

Fenton Z-Score

0.09 (0.91)

0.04 (0.91)

−0.11 (1.0)

PFAS Exposures^

n = 206

  

PFHxS (µg/L)

3.40 (2.0)

3.19 (1.6)

3.08 (1.7)

PFOS (µg/L)

5.73 (2.9)

5.25 (1.7)

5.04 (1.8)

PFOA (µg/L)

1.35 (0.9)

1.14 (1.9)

1.14 (1.9)

PFNA (µg/L)

0.41 (0.2)

0.36 (1.8)

0.37 (1.8)

PFDA (µg/L)

0.16 (0.1)

0.13 (1.8)

0.12 (1.8)

PFUnDA (% above the LOD)

41.3% (85)

35.5% (50)

38.6% (27)

MeFOSAA (% above the LOD)

34% (70)

37.6% (53)

42.9% (30)

  1. 5-hmC: 5-hydroxymethylcytosine; 5-mC: 5-methylcytosine; BMI: body mass index; LOD: limit of detection; MeFOSAA: 2-(N-methyl-perfluorooctane sulfonamido) acetic acid; PFAS: per-/polyfluoroalkyl substances; PFHxS: perfluorohexanesulphonic acid; PFDA: perfluorodecanoic acid; PFNA: perfluorononanoic acid; PFOA: perfluorooctanoic acid; PFOS: perfluorooctanesulfonic acid; PFUnDA: perfluoroundecanoic acid.
  2. *This includes all women originally enrolled in the first trimester. Note that many were lost to follow-up or provided incomplete data. Of these, 288 stayed in the study and had a live, singleton birth at the study hospital (2 were missing information on infant sex). A subset of 206 participants with archived first trimester samples were selected for the PFAS analysis.
  3. ^Numeric PFAS reported in geometric means.